Tolloid-like proteinases orchestrate extracellular matrix formation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Serum decorin and biglycan levels as predictive biomarkers for lung fibrosis severity and mortality risk in COVID-19 patients.Frontiers in medicine · 2024
   Article
2. COVID-19 induces more pronounced extracellular matrix deposition than other causes of ARDS.Respiratory research · 2023
   Article
3. Transforming growth factor-β2 induces expression of biologically active bone morphogenetic protein-1 in human trabecular meshwork cells.Investigative ophthalmology & visual science · 2013
   Article
4. Renal interstitial fibrosis: mechanisms and evaluation.Current opinion in nephrology and hypertension · 2012
   Review

Corrections and comments

• Comment on
  Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as